Literature DB >> 7391960

Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans.

O I Corrigan, C C Su, W I Higuchi, A F Hofmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391960     DOI: 10.1002/jps.2600690739

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  14 in total

Review 1.  Medical aspects of gallstones--1985: sixty years on.

Authors:  R H Dowling; D Gleeson
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

2.  Management of stones in the biliary tree.

Authors:  R H Dowling
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

Review 3.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

4.  Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  A hydrophilic bile acid effects partial dissolution of cholesterol gallstones in the prairie dog.

Authors:  B I Cohen; E H Mosbach; C K McSherry; B Rzigalinski; S Kuroki
Journal:  Lipids       Date:  1986-09       Impact factor: 1.880

6.  Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.

Authors:  H Igimi; S Asakawa; D Watanabe; H Shimura
Journal:  Gastroenterol Jpn       Date:  1983-04

7.  Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.

Authors:  K von Bergmann; A Beck; C Engel; O Leiss
Journal:  Klin Wochenschr       Date:  1987-05-15

8.  Cholesterol (thermodynamic) activity determinations in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation.

Authors:  U K Jain; W I Higuchi; C L Liu; P H Lee; N A Mazer
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

9.  Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.

Authors:  S Sahlin; J Ahlberg; B Angelin; E Reihnér; K Einarsson
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

10.  Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.

Authors:  J L Thistle; N F Larusso; A F Hofmann; J Turcotte; G L Carlson; B J Ott
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.